Robinhood Markets saw its stock plunge nearly 10% on Monday, underperforming broader markets and financial sector peers, as a sharp downturn in Bitcoin and fading retail crypto trading activity sparked investor concerns over its transaction-dependent revenue streams.
Despite a star-studded client list and explosive revenue growth, IonQ's towering valuation and the nascent state of quantum computing signal significant risk for investors eyeing the recent sell-off.
As stock markets cool from years of stellar gains, a disciplined rebalancing is underway. Vanguard data reveals a broad-based move into fixed income, signaling a strategic pivot rather than panic.
Wall Street and the dollar advanced as robust economic indicators and a U.S.-India trade pact overshadowed a continued historic selloff in precious metals. Investors recalibrate around growth optimism and shifting geopolitical winds.
Major U.S. stock indices advanced Monday, setting a positive tone for a week packed with corporate earnings reports from technology giants and other bellwethers. Investor sentiment remains cautiously optimistic as early results surpass expectations.
Investment firm Stanich Group has liquidated its entire position in the iShares ESG Aware USD Corporate Bond ETF (SUSC), a move analysts interpret as a reallocation towards equities amid shifting macroeconomic forecasts.
While its metaverse venture stumbles, Meta Platforms' core advertising engine and strategic shift toward artificial intelligence are convincing analysts it remains the top contender for outperformance among tech's elite group by 2026.
MicroStrategy's massive Bitcoin holdings have fallen below their average purchase price, resulting in over $900 million in paper losses. This development intensifies scrutiny on the company's reliance on equity markets to fund its crypto acquisitions as financial conditions tighten.
Shares of GE Vernova (GEV) have surged over 100% in the past year, closing near $726. As the energy transition play captivates the market, analysts are divided on whether its valuation still offers room to run or signals a peak.
Capital Southwest Corporation (NASDAQ: CSWC) reported strong fourth-quarter revenue growth of 18.2%, surpassing Wall Street expectations. However, the business development company's GAAP earnings per share came in modestly below analyst consensus estimates.
As growth investing maintains its momentum, fueled by economic expansion and AI investment, we analyze three standout ETFs that offer investors diversified, cost-effective exposure to this high-performing segment.
Amid surging government revenue and public protests over its ICE contracts, Palantir CEO Alex Karp defends the company's controversial surveillance technology, framing it as a safeguard against state overreach rather than an enabler.
An AI-driven analysis suggests Cloudflare (NET) shares may face headwinds over the next two months, projecting an average price near $168. The forecast contrasts with bullish long-term analyst views, highlighting the tension between immediate technical signals and the company's strategic positioning in edge security and AI infrastructure.
As the energy sector leads the market in early 2026, ConocoPhillips and Kinder Morgan emerge as compelling picks for investors seeking reliable, growing dividends backed by strong fundamentals and strategic positioning.
While a seven-figure nest egg is a common retirement goal, financial experts caution that its sufficiency hinges on withdrawal strategies, lifestyle expectations, and supplemental income.
The data analytics firm smashed Wall Street forecasts for the fourth quarter, reporting a 70% revenue surge to $1.4 billion, driven by explosive growth in its U.S. operations. Its bullish outlook for 2025 further signals resilience amid sector-wide anxieties.
As economic anxieties mount, strategic diversification remains paramount. We examine two Vanguard ETFs that could offer stability and long-term growth opportunities should market conditions deteriorate.
Bernstein analyst lifts ASML's price target to $1,911, citing a buying opportunity after recent pullback. The chip equipment giant's record Q4 orders and updated guidance signal confidence in the AI-driven semiconductor upcycle.
Clinical-stage biotech Erasca (ERAS) has seen its stock skyrocket over the past 12 months, hitting a multi-year high. While technical momentum is strong, the company remains pre-revenue, with its fate tied to future drug approvals, presenting a classic high-risk, high-reward scenario for investors.
Expedia Group stock rose sharply after announcing an expanded, exclusive partnership with Affirm, making the fintech firm the sole 'Buy Now, Pay Later' provider across its major U.S. travel platforms.
